Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Assist Reprod Genet ; 41(1): 49-61, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-37993579

RESUMEN

PURPOSE: Patients with polycystic ovarian morphology (PCOM) make up 20% cases for assisted reproductive technology (ART). Folliculogenesis is impaired in PCOS. Signaling molecules are involved in follicle development. Dysregulations of intrafollicular environment and signaling molecules are observed in PCOS. Granulosa cells (GCs) and oocytes secrete molecules into follicular fluid by exocytosis of SNAREs. The aim of this study is to evaluate vesicle transport and vesicle fusion proteins (SNAREs) in GCs from PCOS patients who have undergone IVF treatment. METHODS: Follicular fluids were collected from patients who undergo IVF/ICSI with the diagnosis of male factor (n = 10) and PCOS (n = 10) patients. GCs were separated and cultured. Each group of GCs was stimulated with FSH-hCG. The cells were examined under electron microscope. Immunofluorescent labeling was performed on cells for Stx6, SNAP25, StxBP1, FSHr, and KITL. Integrated density was analyzed from images of Stx6, SNAP25, StxBP1, FSHr, and KITL. RESULTS: Intercellular communication occurs by signal molecules; Stx6, SNAP25, and StxBP1 fusion proteins involved in exocytosis were decreased in the GCs of PCOS. There was no increase in in vitro stimulation with FSH-hCG either. In the electron microscope, it was observed that exocytosis of the vesicles was disrupted. CONCLUSIONS: Exocytosis and vesicular dynamics are among the basic physiological functions of human steroidogenic granulosa cells. Follicle development is necessary for production of competent oocytes and ovulation. Understanding the pathophysiology of PCOS at follicular level is important for disease management. According to our findings, deficits in vesicular dynamics of human granulosa cells in may be central to the treatment strategy for PCOS patients.


Asunto(s)
Síndrome del Ovario Poliquístico , Femenino , Humanos , Masculino , Células de la Granulosa/metabolismo , Hormona Folículo Estimulante/genética , Hormona Folículo Estimulante/farmacología , Hormona Folículo Estimulante/metabolismo , Exocitosis/genética , Comunicación Celular
2.
Neuroradiology ; 52(2): 125-34, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19756562

RESUMEN

INTRODUCTION: The toxic effects of onyx, its solvent dimethyl sulphoxide (DMSO), and n-butyl 2-cyanoacrylate (NBCA) were evaluated after infusion into the subaracnoid space of a rabbit model. METHODS: Each of the two various concentrations of onyx, pure DMSO, NBCA, and normal saline solution were percutaneously infused into the pontocerebellar cisternae of 39 domestic male albino rabbits, after which, the brain stems and medial cerebellar tissues were harvested for biochemical and histopathological studies. RESULTS: The specimens infused in various concentration of onyx, DMSO, and NBCA showed neural tissue necrosis and edema with inflammatory cell infitration in the acute stage. Although the mean values of the lipid peroxidase in the control, saline, and NBCA groups were found to be almost similar, they were found to be low in the onyx and DMSO groups. CONCLUSION: This experimental study suggests that NBCA, and various concentrations of onyx and DMSO have toxic effects on the neural tissues of rabbits when infused into the subarachnoid space.


Asunto(s)
Encéfalo/efectos de los fármacos , Dimetilsulfóxido/toxicidad , Enbucrilato/toxicidad , Neurotoxinas/toxicidad , Polivinilos/toxicidad , Solventes/toxicidad , Médula Espinal/efectos de los fármacos , Animales , Encéfalo/patología , Edema Encefálico/inducido químicamente , Edema Encefálico/patología , Dimetilsulfóxido/administración & dosificación , Relación Dosis-Respuesta a Droga , Enbucrilato/administración & dosificación , Peroxidación de Lípido/efectos de los fármacos , Masculino , Necrosis/inducido químicamente , Necrosis/patología , Polivinilos/administración & dosificación , Conejos , Solventes/administración & dosificación , Médula Espinal/patología , Espacio Subaracnoideo
3.
Acta Histochem ; 112(4): 337-44, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19324400

RESUMEN

The aim of the study was to investigate the effects of sildenafil citrate (SC) on renal ischemia reperfusion (I/R) injury in a rat model. Forty eight male Wistar albino rats were randomly assigned into six groups: sham, ischemia, I/R, SC+sham, SC+ischemia and SC+I/R. In the I/R groups, the right kidney was removed and the artery and vein of the left kidney were clamped for 45 min followed by reperfusion for 1 h. In the SC-treated groups, SC dissolved in saline solution was given as a single dose (1 mg/kg) 60 min before the operation. Renal histology was analyzed by scoring the tubular damage and neutrophil infiltration. Tissue myeloperoxidase activity and lipid peroxidation were analyzed. The histological damage and the neutrophil infiltration induced by I/R were significantly less in the SC+I/R group (p = 0.004 and p = 0.003, respectively). Pretreatment with SC significantly diminished the tissue myeloperoxidase activity, indicating the prevention of the neutrophil sequestration into the kidney in the SC+I/R group (p = 0.004); however, it did not result in any changes in lipid peroxidation. Our results in a rat model of ischemia-reperfusion indicate that pre-ischemic treatment with sildenafil citrate can significantly attenuate ischemia/reperfusion-induced renal injury by decreasing leukocyte infiltration.


Asunto(s)
Riñón/efectos de los fármacos , Riñón/patología , Infiltración Neutrófila/efectos de los fármacos , Piperazinas/uso terapéutico , Daño por Reperfusión/tratamiento farmacológico , Sulfonas/uso terapéutico , Animales , Masculino , Purinas/uso terapéutico , Distribución Aleatoria , Ratas , Ratas Wistar , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología , Citrato de Sildenafil , Vasodilatadores/uso terapéutico
4.
Pediatr Hematol Oncol ; 22(4): 265-70, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16020112

RESUMEN

Congenital dyserythropoietic anemia type I (CDA I) is a rare inherited hematological disorder characterized by macrocytic anemia and ineffective erythropoiesis with pathognomonic morphological features that include internuclear chromatin bridges, spongy heterochromatin, and invagination of the cytoplasm into the nuclear area in erythroid precursors. Treatment of anemia with the usual hematinics is without effect and 15% of patients need chronic transfusions. Successful treatment of CDA I with interferon-alpha was noted. The authors report a patient with CDA I who had required transfusions every 2-3 months since the neonatal period and responded to recombinant interferon-alpha therapy with the findings of electron microscopic investigations.


Asunto(s)
Anemia Diseritropoyética Congénita/tratamiento farmacológico , Interferón-alfa/uso terapéutico , Anemia Diseritropoyética Congénita/sangre , Manejo de la Enfermedad , Eritrocitos/efectos de los fármacos , Eritrocitos/patología , Eritrocitos/ultraestructura , Femenino , Humanos , Lactante , Masculino , Microscopía Electrónica , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA